US Medical Early Asset Director– Insights

US Medical Early AssetDirectorInsights

Are you ready to turn ideas into life-changing medicines At AstraZeneca we are committed to addressing the unmet needs of patients worldwide through scientific this role you will play a crucial role inleveragingour scientific capabilities to positively impact patients lives. Reporting directly to theExecutive DirectorUS Medical Early Asset Team Lead you willbe part of a teamfocused on the development of ambitious US medical strategies for our early pipeline. This is an opportunity to seize design and influence across a complex matrix system to ensure US needs are integrated into global development plans.

Accountabilities:
Manager US Medical Early Asset Insightswill own US insight generation and decision analytics for pipeline assets from late discovery through Phase 2. You will translate ambiguity into clear evidence-based recommendations by integrating secondary analytics custom market research competitive intelligence epidemiology and early forecasting. Partnering closely with Global/US Commercial Medical Clinical Development Market Access HEOR and Finance you will shape target product profiles influence trial design pressure-test differentiation hypotheses and inform investment decisions at stage gates.

Key Responsibilities

• Insight Strategy and Roadmap: Define the US insights learning plan across asset stages; prioritize critical unknowns and decision points and map research/analytics to governance milestones.

• Target Product Profile and Asset Shaping: Pressure-test TPP elements (endpoints attributes device/format administration setting line of therapy subsegments) via research and rapid experiments; recommend trade-offs to maximize US value.

• Primary Market Research: Design and lead payer/HCP/patient qualitative and quantitative studies (concept tests message/value testing conjoint/DTU ethnography discrete choicemax-diff) to refine positioning and evidence needs.

• Secondary Analytics: Synthesize syndicated data claims/EMR analyses epidemiology treatment paradigms and policy trends tosizeopportunities refine segmentation andanticipateadoption barriers.

• Competitive Intelligence:Maintaindynamic competitor profiles trial readouts label trajectories and access precedents; run competitor simulations and implications for differentiation and timing.

• Early Forecasting and Scenarios: Build and refine early demand/adoption forecasts market maps and scenario trees; partner with Finance onrNPVand sensitivity analyses that reflect uncertainty and key inflection points.

• Evidence and Trial Design Input: Translate insight into guidance on endpoints comparators PROs inclusion/exclusion and RWE priorities that support future US adoption labeling and access.

• Customer and Ecosystem Mapping:Identifypriority segments (HCPs treatment centers IDNs payers patient pathways) and define decision drivers across the care continuum to inform early brand strategyand initial fieldteamsstructure.

• Value Proposition Development: Co-create early value narratives and differentiation hypotheses; test resonance and credibility with customers and iterate with Medical/HEOR and Market Access.

• Rapid Test-and-Learn: Stand up lightweight experiments (concept sprints ad boards rapid quant) to answer time-sensitive questions ahead of governance gates and external catalysts.

• Communications and Governance: Craft clear concise readouts and recommendations for asset teams and governance; ensure traceability from insight to decision and document assumptions/risks.

• Vendor and Budget Management: Select and manage research/analytics vendors; ensure methodological rigor compliance and on-time on-budget delivery.

• Compliance and Ethics: Conduct research and external engagements in line with US regulations and company policies for pre-approval communications and data privacy.

MinimumQualifications

• Bachelors degree; advanced degree preferred (MBA MPH MS in Market Research/Statistics PharmD or related).

• 5years in pharma/biotech or consulting focused on market insights new product planning or early commercial strategy; US market experience; early development experience (Phase 12) strongly preferred.

• Demonstrated impact shaping TPPs influencing clinical/evidence plans and informing investment decisions via robust insights and analytics.

• Effective atpartnering with Clinical Medical Market Access/HEOR and Finance; leads without authority in matrixed teams.

Preferred Qualifications

• Hands-on experience with qualitative and quantitative methods (e.g. conjoint/DCE segmentation ATU/DTU message testing) and vendor oversight.

• Proficiencywith forecasting basics epidemiology inputs claims/EMR analytics and triangulation across data sources; comfort with uncertainty and sensitivity testing.

• Ability to translate competitor clinical and access moves into implications for positioning and evidence.

• Clear concise communicator who turns complex data into actionable recommendations for senior stakeholders and governance.

• Working knowledge of analytics and visualization tools (e.g. Excel PowerPoint; familiarity with data platforms/BI tools is a plus).

• Practical experience using AI/ML-enabled tools for insights work (e.g. NLP for unstructured text predictive modeling synthetic respondent methods automated coding of qual prompt engineering for analysis/synthesis) with an understanding of data privacy bias and validation best practices.

This position is based at our Wilmington DE campus headquarters for our US Biopharma we put unexpected teams in the same room we unleash bold thinking with the power to inspire life-changing -person working gives us the platform we need to connect work atpaceand challenge perceptions.Thatswhy we work on average a minimum of three days per week from the office. But thatdoesntmeanwerenot flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.

Next Steps Apply Today!

Are you ready to make a difference Apply now and join our mission to transform lives with our science!